Skip to Content

93 233 (Ondansetron 4 mg)

Pill imprint 93 233 has been identified as Ondansetron hydrochloride 4 mg.

Ondansetron is used in the treatment of nausea/vomiting; gastroenteritis; alcohol dependence; obsessive compulsive disorder; nausea/vomiting, postoperative (and more), and belongs to the drug class 5HT3 receptor antagonists. There is no proven risk in humans during pregnancy. Ondansetron 4 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ondansetron hydrochloride 4 mg 93 233
Ondansetron hydrochloride 4 mg 93 233
Ondansetron hydrochloride 4 mg 93 233
Ondansetron hydrochloride
93 233
4 mg
7.00 mm
Prescription only
Drug Class:
5HT3 receptor antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Teva Pharmaceuticals USA
National Drug Code (NDC):
Inactive Ingredients:
hypromellose 2910 (5 mPa.s)
lactose monohydrate
magnesium stearate
microcrystalline cellulose
corn starch
polyethylene glycol 6000
polyethylene glycol 400
sodium starch glycolate type A potato
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
35356-0197 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.